Mascot Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.42 M
as on 04-12-2024
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.40 Cr
as on 04-12-2024
- Revenue 32.26%
(FY 2022)
- Profit 42.44%
(FY 2022)
- Ebitda 17.14%
(FY 2022)
- Net Worth 16.80%
(FY 2022)
- Total Assets 35.36%
(FY 2022)
About Mascot Biotech (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.42 M.
The company currently has active open charges totaling ₹1.40 Cr.
Manoj Garg, Pranav Garg, Mahavir Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397RJ2006PTC022877
- Company No.
022877
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Kota, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Mascot Biotech (India) Private Limited offer?
Mascot Biotech (India) Private Limited offers a wide range of products and services, including Protein Powder, Vanilla Protein Powder.
Who are the key members and board of directors at Mascot Biotech (India)?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Garg  | Director | 28-Jul-2006 | Current |
| Pranav Garg | Director | 27-Jul-2024 | Current |
| Mahavir Jain | Director | 16-Jun-2023 | Current |
| Malti Garg | Director | 05-Oct-2011 | Current |
Financial Performance and Corporate Structure Insights of Mascot Biotech (India).
Mascot Biotech (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.26% increase. The company also saw a substantial improvement in profitability, with a 42.44% increase in profit. The company's net worth Soared by an impressive increase of 16.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mascot Biotech (India)?
In 2021, Mascot Biotech (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Feb 2022 | ₹2.20 M | Open |
Others Creation Date: 05 Dec 2009 | ₹1.18 Cr | Open |
How Many Employees Work at Mascot Biotech (India)?
Unlock and access historical data on people associated with Mascot Biotech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mascot Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mascot Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
